Previous close | 0.00 |
Open | 221.05 |
Bid | 190.13 x 1200 |
Ask | 208.82 x 2200 |
Day's range | 205.50 - 221.05 |
52-week range | 149.04 - 237.38 |
Volume | |
Avg. volume | 62 |
Market cap | 13.135B |
Beta (5Y monthly) | 0.47 |
PE ratio (TTM) | 52.94 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 2.84 (1.44%) |
Ex-dividend date | 17 Sept 2024 |
1y target est | N/A |
Cochlear (ASX:COH) is navigating a dynamic environment marked by both opportunities and challenges. Recent highlights include a notable 31.2% increase in dividend payouts and innovative product launches, juxtaposed against a 16.7% drop in Q2 net sales and inflationary pressures. In the discussion that follows, we will delve into Cochlear's financial health, operational inefficiencies, strategic growth initiatives, and external threats to provide a comprehensive overview of the company's...
Cochlear (ASX:COH) is navigating a dynamic environment marked by both opportunities and challenges. Recent highlights include a 15% revenue increase and significant R&D investments, counterbalanced by emerging market slowdowns and high integration costs. In the discussion that follows, we will delve into Cochlear's financial health, operational inefficiencies, strategic growth initiatives, and external threats to provide a comprehensive overview of the company's current business situation.
Cochlear Limited ( ASX:COH ) shareholders might be concerned after seeing the share price drop 11% in the last quarter...